These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8247946

  • 1. [Results of alternating treatment of multiple myeloma--cytostatics VBMCP and recombinant interferon alfa-2B].
    Gola A, Usnarska-Zubkiewicz L, Wołowiec D, Urbaniak-Kujda D, Kotlarek-Haus S.
    Pol Arch Med Wewn; 1993 Aug; 90(2):134-41. PubMed ID: 8247946
    [Abstract] [Full Text] [Related]

  • 2. Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
    Oken MM, Kyle RA, Greipp PR, Kay NE, Tsiatis A, Gregory SA, Spiegel R J, O'Connell M J.
    Leuk Lymphoma; 1996 Feb; 20(5-6):447-52. PubMed ID: 8833401
    [Abstract] [Full Text] [Related]

  • 3. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
    Oken MM, Leong T, Lenhard RE, Greipp PR, Kay NE, Van Ness B, Keimowitz RM, Kyle RA.
    Cancer; 1999 Sep 15; 86(6):957-68. PubMed ID: 10491521
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
    Oken MM, Harrington DP, Abramson N, Kyle RA, Knospe W, Glick JH.
    Cancer; 1997 Apr 15; 79(8):1561-7. PubMed ID: 9118039
    [Abstract] [Full Text] [Related]

  • 6. Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
    Salmon SE, Crowley JJ, Grogan TM, Finley P, Pugh RP, Barlogie B.
    J Clin Oncol; 1994 Nov 15; 12(11):2405-14. PubMed ID: 7964957
    [Abstract] [Full Text] [Related]

  • 7. Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantation.
    Kyle RA, Leong T, Li S, Oken MM, Kay NE, Van Ness B, Greipp PR.
    Cancer; 2006 May 01; 106(9):1958-66. PubMed ID: 16565956
    [Abstract] [Full Text] [Related]

  • 8. The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.
    Kyle RA, Jacobus S, Friedenberg WR, Slabber CF, Rajkumar SV, Greipp PR.
    Cancer; 2009 May 15; 115(10):2155-64. PubMed ID: 19248045
    [Abstract] [Full Text] [Related]

  • 9. Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
    Bladé J, San Miguel JF, Alcalá A, Maldonado J, Sanz MA, García-Conde J, Moro MJ, Alonso C, Besalduch J, Zubizarreta A.
    J Clin Oncol; 1993 Jun 15; 11(6):1165-71. PubMed ID: 8501503
    [Abstract] [Full Text] [Related]

  • 10. Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience.
    Cohen AM, Meytes D, Many A, Brenner B, Aghai E, Shaklai M, Kaufman S, Shtalrid M, Attias D, Manor Y.
    Isr J Med Sci; 1995 Oct 15; 31(10):604-10. PubMed ID: 7591683
    [Abstract] [Full Text] [Related]

  • 11. Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: interim results.
    Ludwig H, Cohen AM, Huber H, Nachbaur D, Jungi WF, Senn H, Günczler P, Schüller J, Eckhardt S, Seewann HL.
    Eur J Cancer; 1991 Oct 15; 27 Suppl 4():S40-5. PubMed ID: 1799476
    [Abstract] [Full Text] [Related]

  • 12. [Chemotherapy and immunomodulating treatment of patients with multiple myeloma].
    Kraj M, Dmoszyńska A, Maj S, Kowalewski J, Rostkowska J, Pogłód R, Sokołowska B, Mendek-Czajkowska E, Kurowska M, Sokołowska U.
    Acta Haematol Pol; 1991 Oct 15; 22(1):4-20. PubMed ID: 1823965
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy for multiple myeloma with melphalan, prednisone, cyclophosphamide, vincristine, and carmustine (BCNU) (M-2 protocol).
    Tirelli U, Crivellari D, Carbone A, Veronesi A, Galligioni E, Trovò MG, Tumolo S, Grigoletto E.
    Cancer Treat Rep; 1982 Nov 15; 66(11):1971-3. PubMed ID: 6897205
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.
    Liu P, Leong T, Quam L, Billadeau D, Kay NE, Greipp P, Kyle RA, Oken MM, Van Ness B.
    Blood; 1996 Oct 01; 88(7):2699-706. PubMed ID: 8839865
    [Abstract] [Full Text] [Related]

  • 16. Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology).
    Bladé J, San Miguel JF, Escudero ML, Fontanillas M, Besalduch J, Gardella S, Arias J, García-Conde J, Carnero M, Marti JM, Rozman C, Estapé J, Montserrat E.
    Leukemia; 1998 Jul 01; 12(7):1144-8. PubMed ID: 9665202
    [Abstract] [Full Text] [Related]

  • 17. Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.
    Boccadoro M, Avvisati G, Cantonetti M, Cavo-Comotti BM, Frieri R, Gallamini A, Gallone G, Lauta VM, Liberati M, Marmont F.
    Pathol Biol (Paris); 1990 Oct 01; 38(8):829. PubMed ID: 2274374
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group.
    Peest D, Deicher H, Coldewey R, Leo R, Bartl R, Bartels H, Braun HJ, Fett W, Fischer JT, Göbel B.
    Eur J Cancer; 1995 Oct 01; 31A(2):146-51. PubMed ID: 7718318
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
    Montalbán C, Sevilla F, Zapatero A, Blanco L, Sabán J, Serrano M, Serrano Ríos M.
    Rev Clin Esp; 1985 May 01; 176(8):392-5. PubMed ID: 3839590
    [No Abstract] [Full Text] [Related]

  • 20. Strategies for combining interferon with chemotherapy for the treatment of multiple myeloma.
    Oken MM, Kyle RA.
    Semin Oncol; 1991 Oct 01; 18(5 Suppl 7):30-2. PubMed ID: 1948126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.